Zentera Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$75M
- Investors
-
12
Zentera Therapeutics General Information
Description
Manufacturer of small-molecule oncology therapeutics designed to address unmet medical needs in solid and hematologic cancers. The company offers clinical-stage drug candidates targeting cancer-related biological pathways, including therapies focused on WEE1, BCL-2, and estrogen receptor targets, enabling oncologists, cancer patients, and healthcare institutions to access precision treatment options with improved disease management potential.
Contact Information
Website
www.zenteratx.comCorporate Office
- 29th Floor, Block A, Phase III, Xujiahui Center
- Number 183 Hongqiao Road, Xuhui District, Shanghai (Unit 2903-07)
- Shanghai, 200011
- China
Corporate Office
- 29th Floor, Block A, Phase III, Xujiahui Center
- Number 183 Hongqiao Road, Xuhui District, Shanghai (Unit 2903-07)
- Shanghai, 200011
- China
Zentera Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 02-Aug-2021 | $75M | Completed | Clinical Trials - General | ||
| 2. Early Stage VC (Series A) | 20-May-2020 | Completed | Clinical Trials - General | |||
| 1. Joint Venture | 15-May-2020 | Completed | Clinical Trials - General |
Zentera Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Avidity Partners | Asset Manager | Minority | ||
| Casdin Capital | Venture Capital | Minority | ||
| Farallon Capital Management | Hedge Fund | Minority | ||
| LAV (Lilly Asia Fund) | Corporate Venture Capital | Minority | ||
| Logos Capital | Hedge Fund | Minority |
Zentera Therapeutics Investments (1)
Zentera Therapeutics’s most recent deal was a Joint Venture with Zentera Alpha. The deal was made on 01-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Zentera Alpha | 01-Jan-2022 | Joint Venture | Drug Discovery |
Zentera Therapeutics FAQs
-
When was Zentera Therapeutics founded?
Zentera Therapeutics was founded in 2020.
-
Where is Zentera Therapeutics headquartered?
Zentera Therapeutics is headquartered in Shanghai, China.
-
What industry is Zentera Therapeutics in?
Zentera Therapeutics’s primary industry is Drug Discovery.
-
Is Zentera Therapeutics a private or public company?
Zentera Therapeutics is a Private company.
-
What is Zentera Therapeutics’s current revenue?
The current revenue for Zentera Therapeutics is .
-
How much funding has Zentera Therapeutics raised over time?
Zentera Therapeutics has raised $95M.
-
Who are Zentera Therapeutics’s investors?
Avidity Partners, Casdin Capital, Farallon Capital Management, LAV (Lilly Asia Fund), and Logos Capital are 5 of 12 investors who have invested in Zentera Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process